Tag: adventure

Posts with tag: adventure

Latest Posts

Palantir Stock Falls on Report of Pentagon Budget Cuts

Palantir (PLTR) stock plunged after a Washington Post report said the Trump administration plans to cut the Pentagon's budget, potentially reducing Palantir's government contracts.

Drug Lobbyists Call for Reforms as PBMs Face Bipartisan Scrutiny

Drug companies and pharmacy benefit managers are clashing in Washington, D.C. over rebate strategies amid rising scrutiny of PBM practices. CVS defends PBMs' role in lowering branded drug costs, despite industry shifts toward generic and low-cost options from Walmart, GoodRx, and telehealth companies.

Airbus CEO Wants EU to Relax Stance for Space Merger

Airbus CEO seeks EU antitrust approval for space merger talks with Thales and Leonardo.

US Stock Futures Dip as Fed Hints at Rate Pause

U.S. stock futures slipped on Thursday after the S&P 500 reached a record high, with investors digesting the latest sign that the Federal Reserve is unlikely to cut rates anytime soon.

DOGE Commission: A Billionaire's Budget Bonanza or Bureaucratic Bloodbath?

Elon Musk's DOGE commission claims billions in government efficiency savings, but analysis reveals the actual savings may be significantly lower and some of the cuts could have negative economic consequences.

Trump Orders Massive Regulatory Review, Cuts Dozens of Federal Entities

President Trump signs executive orders to massively review regulations and reduce federal entities, aiming to eliminate burdens on businesses and cut government spending and programs.

US Future Markets Slump on Fed Rate Pause, Trade Concerns

US future markets drop after record highs; Fed minutes suggest pause in rate cuts

U.S. Futures Slip After S&P 500 Hits Record High Again

US future markets fall after the S&P 500 reached a record high for the second time in a row, and investors digested the latest sign the Federal Reserve is unlikely to cut rates anytime soon.

CVS, Pharma Giants Battle Over PBMs

A battle is brewing in Washington, D.C., between pharmaceutical companies and pharmacy benefit managers (PBMs) as President Donald Trump's new administration takes shape. The drug industry's biggest lobbying firm, PhRMA, has released its policy priorities for 2025, including putting patients before PBM profits. That has spurred PBMs like CVS Caremark (CVS) to defend their companies' value in the overall healthcare system.

Suzuki aims for double-digit profit margin, 15% ROE by mid-decade

Suzuki Motor targets 10% operating profit margin, 15% ROE by fiscal 2030